EMEA-002115-PIP01-17

Key facts

Active substance
Pretomanid
Therapeutic area
Infectious diseases
Decision number
P/0058/2019
PIP number
EMEA-002115-PIP01-17
Pharmaceutical form(s)
dispersible tablet
Condition(s) / indication(s)
Treatment of multi-drug-resistant tuberculosis
Route(s) of administration
Oral use
Contact for public enquiries
Global Alliance for TB Drug Development

Tel. +1 2122277450
E-mail: info@tballiance.org

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating